Trinucleotide Repeats Number in SCA2, SCA3, and SCA17 in Early-Onset Parkinson's Disease
暂无分享,去创建一个
Y. Sohn | C. Lyoo | Joong-Seok Kim | J. Kim | S. Chung | Y. Kim | Hyeo-il Ma | P. Lee | Sang Jin Kim | M. Lee | Myoung-Chong Lee | Y. Sung | S. Kang | J. Choi | J. Baik | Hae-Won Shin | M. Park | Myoung-Soo Woo | Semi Kim | Jin Ho Kim | Hyeo-Il Ma | J. Kim | Jae Woo Kim
[1] Yu Kyeong Kim,et al. Importance of low-range CAG expansion and CAA interruption in SCA2 Parkinsonism. , 2007, Archives of neurology.
[2] S. Tsuji,et al. Polyglutamine disease: Recent advances in the neuropathology of dentatorubral‐pallidoluysian atrophy , 2006, Neuropathology : official journal of the Japanese Society of Neuropathology.
[3] Yi Zhao,et al. Genetic analysis of SCA2, 3 and 17 in idiopathic Parkinson's disease , 2006, Neuroscience Letters.
[4] T. Klockgether,et al. Dopamine transporter positron emission tomography in spinocerebellar ataxias type 1, 2, 3, and 6. , 2005, Archives of neurology.
[5] D. Hernandez,et al. Analysis of SCA-2 and SCA-3 repeats in Parkinsonism: Evidence of SCA-2 expansion in a family with autosomal dominant Parkinson's disease , 2005, Neuroscience Letters.
[6] K. Gwinn‐Hardy,et al. Analysis of polyglutamine-coding repeats in the TATA-binding protein in different neurodegenerative diseases , 2005, Journal of Neural Transmission.
[7] Ren-Shyan Liu,et al. Presence of spinocerebellar ataxia type 2 gene mutation in a patient with apparently sporadic Parkinson's disease: Clinical implications , 2004, Movement disorders : official journal of the Movement Disorder Society.
[8] N W Wood,et al. Trinucleotide repeats and neurodegenerative disease. , 2004, Brain : a journal of neurology.
[9] T. Yen,et al. The parkinsonian phenotype of spinocerebellar ataxia type 3 in a Taiwanese family. , 2004, Parkinsonism & related disorders.
[10] P. Lockhart,et al. Profile of families with parkinsonism‐predominant spinocerebellar ataxia type 2 (SCA2) , 2004, Movement disorders : official journal of the Movement Disorder Society.
[11] K. Gwinn‐Hardy,et al. Genetic testing in spinocerebellar ataxia in Taiwan: expansions of trinucleotide repeats in SCA8 and SCA17 are associated with typical Parkinson's disease , 2004, Clinical genetics.
[12] M. Oda,et al. Possible reduced penetrance of expansion of 44 to 47 CAG/CAA repeats in the TATA-binding protein gene in spinocerebellar ataxia type 17. , 2004, Archives of neurology.
[13] Karen Marder,et al. Familial aggregation of early‐ and late‐onset Parkinson's disease , 2003, Annals of neurology.
[14] V. Kostic,et al. SCA2 and SCA3 mutations in young‐onset dopa‐responsive parkinsonism , 2003, European journal of neurology.
[15] Willibald Gerschlager,et al. Chronic thalamic stimulation in a patient with spinocerebellar ataxia type 2 , 2003, Movement disorders : official journal of the Movement Disorder Society.
[16] P. Lockhart,et al. SCA-2 presenting as parkinsonism in an Alberta family , 2002, Neurology.
[17] K. Marder,et al. Role of SCA2 mutations in early‐ and late‐onset dopa‐responsive parkinsonism , 2002, Annals of neurology.
[18] S. Tsuji,et al. Trinucleotide repeats in 202 families with ataxia: a small expanded (CAG)n allele at the SCA17 locus. , 2002, Archives of neurology.
[19] B. Jeon,et al. Molecular analysis of Spinocerebellar ataxias in Koreans: frequencies and reference ranges of SCA1, SCA2, SCA3, SCA6, and SCA7. , 2001, Molecules and cells.
[20] Changming Sun,et al. Spinocerebellar ataxia type 2 presenting as familial levodopa‐responsive parkinsonism , 2001, Annals of neurology.
[21] C. Broeckhoven,et al. CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia. , 2001, Brain : a journal of neurology.
[22] I. Kanazawa,et al. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. , 2001, Human molecular genetics.
[23] P. Vieregge,et al. Different types of repeat expansion in the TATA-binding protein gene are associated with a new form of inherited ataxia , 2001, European Journal of Human Genetics.
[24] M. Farrer,et al. Spinocerebellar ataxia type 3 phenotypically resembling parkinson disease in a black family. , 2001, Archives of neurology.
[25] S. Tsuji,et al. Pathology of CAG repeat diseases , 2000, Neuropathology : official journal of the Japanese Society of Neuropathology.
[26] M. Farrer,et al. Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese , 2000, Neurology.
[27] B. Jeon,et al. Spinocerebellar ataxia type 2 in seven Korean families: CAG trinucleotide expansion and clinical characteristics. , 1999, Journal of Korean medical science.
[28] Georg Auburger,et al. Spinocerebellar ataxia 2 (SCA2): morphometric analyses in 11 autopsies , 1999, Acta Neuropathologica.
[29] J W Langston,et al. Parkinson disease in twins: an etiologic study. , 1999, JAMA.
[30] G. Rouleau,et al. Fluorodopa and raclopride PET analysis of patients with Machado-Joseph disease , 1997, Neurology.
[31] P. S. St George-Hyslop,et al. Dopa‐responsive parkinsonism phenotype of Machado‐Joseph disease: Confirmation of 14q CAG expansion , 1995, Annals of neurology.
[32] C. S. Lu,et al. Genetic and DAT imaging studies of familial parkinsonism in a Taiwanese cohort. , 2006, Journal of neural transmission. Supplementum.
[33] K. Gwinn‐Hardy. When is ataxia not ataxia? , 2004, Archives of neurology.
[34] Hsiu-Chen Chang,et al. The parkinsonian phenotype of spinocerebellar ataxia type 2. , 2004, Archives of neurology.
[35] 小出 玲爾,et al. A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene : a new polyglutamine disease? , 2000 .
[36] D. Borchelt,et al. Polyglutamine pathogenesis. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.